Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Arcadia Bio (RKDA)

Arcadia Bio (RKDA)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 45,738
  • Shares Outstanding, K 8,646
  • Annual Sales, $ 1,460 K
  • Annual Income, $ -13,480 K
  • 60-Month Beta -2.97
  • Price/Sales 30.71
  • Price/Cash Flow N/A
  • Price/Book 2.78

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/19
See More
  • Average Estimate -0.65
  • Number of Estimates 2
  • High Estimate -0.61
  • Low Estimate -0.68
  • Prior Year -0.14
  • Growth Rate Est. (year over year) -364.29%

Price Performance

See More
Period Period Low Period High Performance
1-Month
3.85 +37.40%
on 11/11/19
5.60 -5.54%
on 12/02/19
-0.48 (-8.32%)
since 11/06/19
3-Month
3.85 +37.40%
on 11/11/19
6.75 -21.63%
on 09/10/19
-1.25 (-19.11%)
since 09/06/19
52-Week
1.82 +190.66%
on 08/05/19
10.40 -49.13%
on 02/28/19
+1.37 (+34.95%)
since 12/06/18

Most Recent Stories

More News
Verdeca Receives Approval of HB4® Drought and Herbicide Tolerant Soybeans in Paraguay

Verdeca, a joint venture between Arcadia Biosciences, Inc. (Nasdaq: RKDA) and Bioceres Crop Solutions Corp. (NYSE American: BIOX), announced today it has successfully completed the regulatory review process...

RKDA : 5.29 (+1.73%)
Approval of HB4(R) Drought and Herbicide Tolerant Soybeans in Paraguay

-- HB4 trait now has regulatory approval in top four global suppliers of soybean, accounting for more than 80 percent of total production --

RKDA : 5.29 (+1.73%)
Arcadia Biosciences: 3Q Earnings Snapshot

DAVIS, Calif. (AP) _ Arcadia Biosciences Inc. (RKDA) on Wednesday reported a third-quarter loss of $14.2 million, after reporting a profit in the same period a year earlier.

RKDA : 5.29 (+1.73%)
Arcadia Biosciences Announces Third-Quarter 2019 Financial Results and Business Highlights

Arcadia Biosciences, Inc. (Nasdaq: RKDA), a leader in science-based approaches to enhancing the quality and nutritional content of crops, today released its financial results and business highlights for...

RKDA : 5.29 (+1.73%)
Arcadia Biosciences Announces Wheat Purchase Commitment, Significant Increase in GoodWheat(TM) Harvest Acres

Arcadia Biosciences, Inc. (Nasdaq: RKDA), a leader in science-based approaches to enhancing the quality and nutritional value of crops and food ingredients, today announced it has secured its first purchase...

RKDA : 5.29 (+1.73%)
Arcadia Biosciences Announces Date of Third-Quarter 2019 Financial Results and Business Highlights Conference Call

Arcadia Biosciences, Inc. (Nasdaq: RKDA), a leader in science-based approaches to enhancing the quality and nutritional value of crops, today announced that it will release its third-quarter 2019 financial...

RKDA : 5.29 (+1.73%)
Arcadia Biosciences Advances Hemp Operations with Archipelago Ventures

Arcadia Biosciences, Inc. (Nasdaq: RKDA), a leader in science-based approaches to enhancing the quality and nutritional value of crops and food ingredients, today issued an update on its recently formed...

RKDA : 5.29 (+1.73%)
Thinking about buying stock in Aurora Cannabis, Beyond Meat, Exact Sciences, Plus Therapeutics, or Arcadia Biosciences?

InvestorsObserver issues critical PriceWatch Alerts for ACB, BYND, EXAS, PSTV, and RKDA.

RKDA : 5.29 (+1.73%)
ACB.TO : 3.21 (unch)
Arcadia Biosciences Granted U.S. Patent for Reduced Gluten GoodWheat

Arcadia Biosciences, Inc. (Nasdaq: RKDA), a leader in science-based approaches to enhancing the quality and nutritional value of crops and food ingredients, today announced the U.S. Patent and Trademark...

RKDA : 5.29 (+1.73%)
Arcadia Biosciences Announces Closing of $10 Million Registered Direct Offering Priced At-the-Market

Arcadia Biosciences, Inc. (Nasdaq: RKDA), a food ingredient company and proven leader in agricultural innovation, improving the quality and nutritional content of crops, today announced the closing of...

RKDA : 5.29 (+1.73%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Buy with a Weakest short term outlook on maintaining the current direction.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Trade RKDA with:

Business Summary

Arcadia Biosciences, Inc. is engaged in developing and commercializing agricultural products primarily in the United States. The Company's product includes nitrogen use crops, salt tolerant plants, sunflower oil and shelf-life produce. Arcadia Biosciences, Inc. is headquartered in Davis, California.

See More

Key Turning Points

2nd Resistance Point 5.43
1st Resistance Point 5.36
Last Price 5.29
1st Support Level 5.19
2nd Support Level 5.10

See More

52-Week High 10.40
Fibonacci 61.8% 7.12
Fibonacci 50% 6.11
Last Price 5.29
Fibonacci 38.2% 5.10
52-Week Low 1.82

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar